Yun-Tzu Lin Chien-Feng Li Hung-Chang Wu Yi-Hua Jan Yu-Hsuan Kuo
10.3389/fimmu.2023.1131448
Front Immunol
2023 Mar 27;14:1131448.
brg1 smarca4 swi/snf check-point inhibitors lung cancer nivolumab non-small cell lung carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37051241/
Carcinoma / genetics Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics Carcinoma, Non-Small-Cell Lung / pathology Lung Neoplasms / diagnosis Lung Neoplasms / drug therapy Lung Neoplasms / genetics
Carcinoma / genetics Carcinoma, Non-Small-Cell Lung / drug therapy Carcinoma, Non-Small-Cell Lung / genetics Carcinoma, Non-Small-Cell Lung / pathology Lung Neoplasms / diagnosis Lung Neoplasms / drug therapy Lung Neoplasms / genetics Case Reports Aged DNA Helicases / genetics Humans Male Nivolumab / therapeutic use Nuclear Proteins / genetics Transcription Factors / genetics Nivolumab SMARCA4 protein, human DNA Helicases Nuclear Proteins Transcription Factors
PMC10083322
37051241
Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
2023